Literatura académica sobre el tema "Cancer drug resistance, tumor metabolism"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Cancer drug resistance, tumor metabolism".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Cancer drug resistance, tumor metabolism"
Yoo, Hee-Chan y Jung-Min Han. "Amino Acid Metabolism in Cancer Drug Resistance". Cells 11, n.º 1 (2 de enero de 2022): 140. http://dx.doi.org/10.3390/cells11010140.
Texto completoChen, Xun, Shangwu Chen y Dongsheng Yu. "Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance". Metabolites 10, n.º 7 (16 de julio de 2020): 289. http://dx.doi.org/10.3390/metabo10070289.
Texto completoTiek, Deanna y Shi-Yuan Cheng. "DNA damage and metabolic mechanisms of cancer drug resistance". Cancer Drug Resistance 5, n.º 2 (2022): 368–79. http://dx.doi.org/10.20517/cdr.2021.148.
Texto completoVarghese, Elizabeth, Samson Mathews Samuel, Alena Líšková, Marek Samec, Peter Kubatka y Dietrich Büsselberg. "Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer". Cancers 12, n.º 8 (12 de agosto de 2020): 2252. http://dx.doi.org/10.3390/cancers12082252.
Texto completoAlfarouk, Khalid O. "Tumor metabolism, cancer cell transporters, and microenvironmental resistance". Journal of Enzyme Inhibition and Medicinal Chemistry 31, n.º 6 (10 de febrero de 2016): 859–66. http://dx.doi.org/10.3109/14756366.2016.1140753.
Texto completoRoy, Sukanya, Subhashree Kumaravel, Ankith Sharma, Camille L. Duran, Kayla J. Bayless y Sanjukta Chakraborty. "Hypoxic tumor microenvironment: Implications for cancer therapy". Experimental Biology and Medicine 245, n.º 13 (27 de junio de 2020): 1073–86. http://dx.doi.org/10.1177/1535370220934038.
Texto completoMoiseenko, Fedor V., Nikita Volkov, Alexey Bogdanov, Michael Dubina y Vladimir Moiseyenko. "Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion". F1000Research 6 (17 de marzo de 2017): 288. http://dx.doi.org/10.12688/f1000research.10992.1.
Texto completoQian, Yanrong, Reetobrata Basu, Joseph Terry, Samuel Casey Mathes, Nathan Arnett, Cole Smith, Isaac Mendez-Gibson et al. "Antagonism of Growth Hormone Receptor Suppresses Cancer Growth and Drug Resistance in Mice". Journal of the Endocrine Society 5, Supplement_1 (1 de mayo de 2021): A1011—A1012. http://dx.doi.org/10.1210/jendso/bvab048.2069.
Texto completoWen, Gui-Min, Xiao-Yan Xu y Pu Xia. "Metabolism in Cancer Stem Cells: Targets for Clinical Treatment". Cells 11, n.º 23 (26 de noviembre de 2022): 3790. http://dx.doi.org/10.3390/cells11233790.
Texto completoBhardwaj, Vikas y Jun He. "Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer". International Journal of Molecular Sciences 21, n.º 10 (12 de mayo de 2020): 3412. http://dx.doi.org/10.3390/ijms21103412.
Texto completoTesis sobre el tema "Cancer drug resistance, tumor metabolism"
E, Pranzini. "Metabolic reprogramming of colorectal cancer cells resistant to 5-FU". Doctoral thesis, Università di Siena, 2020. http://hdl.handle.net/11365/1095546.
Texto completoShahi, Thakuri Pradip. "MODELING ANTI-CANCER DRUG RESISTANCE USING TUMOR SPHEROIDS". University of Akron / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=akron1574725861735168.
Texto completoKala, Shashwati. "Role of ginsenoside Rb1 and its metabolite compound K in attenuating chemoresistance and tumour-initiating properties of ovarian cancer cells". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/207178.
Texto completoChau, Wing-ka y 周穎嘉. "Characterization of ovarian tumor-initiating cells and mechanisms of chemoresistance". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/197834.
Texto completopublished_or_final_version
Biological Sciences
Master
Master of Philosophy
Kim, Gloria J. "Cancer nanotechnology engineering multifunctional nanostructures for targeting tumor cells and vasculatures /". Diss., Atlanta, Ga. : Georgia Institute of Technology, 2007. http://hdl.handle.net/1853/22610.
Texto completoCommittee Chair: Nie, Shuming; Committee Member: Lyon, L. Andrew; Committee Member: McIntire, Larry V.; Committee Member: Murthy, Niren; Committee Member: Prausnitz, Mark R.
Rajabi, Fatemeh. "Role of the xenoreceptor PXR (NR1I2) in colon cancer stem cells drug resistance and tumor relapse". Thesis, Montpellier, 2015. http://www.theses.fr/2015MONTT027.
Texto completoTumor recurrence is one of the major obstacles to overcome in the future to improve overall survival of patients with colon cancer. High rates and patterns of therapeutic failure seen in patients are consistent with a steady accumulation of drug-resistant cancer stem cells (CSCs). Here, we demonstrate that the nuclear receptor PXR (NR1I2) acts as a key regulator of colon CSC chemoresistance and of their ability to generate post-treatment tumor relapse. We first determined that the enrichment of PXR paralleled that of CSC markers upon treatment of colon cancer cells with standard of care chemotherapy. We found that PXR was highly expressed in colorectal cancer cells displaying CSC markers and function and that it was instrumental for the emergence of CSCs following chemotherapy in vitro and in vivo. mRNA profiling experiments in colon CSCs indicated that PXR transcriptionally controls a large network of genes including markers of stemness, genes involved in resistance to drug/apoptosis or migration/invasion. Finally, PXR down-regulation altered the survival and self-renewal of colon CSCs in vitro and hampered their capacity to resist chemotherapy in vivo, leading to significant delays of post-chemotherapy tumor relapse. This study strongly suggests that targeting PXR may represent a novel treatment strategy to prevent drug resistance and recurrence through the sensitization of CSCs to standard chemotherapy. Taken together, our data strongly suggest that PXR plays an instrumental role in the so-called "intrinsic" pan-resistance of CSCs against therapy
Iliopoulos, Dimitrios. "The role of the WWOX tumor suppressor in breast and lung cancer". Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1155142398.
Texto completoIPPOLITO, LUIGI. "OXPHOS - a metabolic switch driven by tumor microenvironment and resistance to therapy in prostate carcinoma". Doctoral thesis, Università di Siena, 2016. http://hdl.handle.net/11365/1006820.
Texto completoWang, Xuan. "Internalization of Extracellular ATP by Cancer Cells and its Functional Roles in Cancer Drug Resistance". Ohio University / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ohiou1505834714683835.
Texto completoBalcells, Nadal Cristina. "The supramolecular organization of cancer metabolism: From macromolecular crowding to metabolic reprogramming underlying cancer metastasis and drug resistance". Doctoral thesis, Universitat de Barcelona, 2019. http://hdl.handle.net/10803/668321.
Texto completoLibros sobre el tema "Cancer drug resistance, tumor metabolism"
Dr, Mehta Kapil y Siddik Zahid H, eds. Drug resistance in cancer cells. New York, NY: Springer, 2009.
Buscar texto completoBenjamin, Bonavida, ed. Sensitization of cancer cells for chemo/immuno/radio-therapy. Totowa, NJ: Humana Press, 2008.
Buscar texto completoS, El-Deiry Wafik, ed. Tumor progression and therapeutic resistance. New York, NY: New York Academy of Sciences, 2005.
Buscar texto completoB, Roninson Igor, ed. Molecular and cellular biology of multidrug resistance in tumor cells. New York: Plenum Press, 1991.
Buscar texto completoLauricella, Marianna y Sonia Emanuele. Novel apoptotic drugs in targeting tumor cells. Trivandrum, Kerala, India: Researh Signpost, 2007.
Buscar texto completoKim, Kŏn-hong. Yubangam ŭi taje yangmul naesŏng saengchʻe chipʻyo palgul mit kŭ yuyongsŏng kŏmjŭng =: Identification of biomarkers for multidrug resistance and validation of markers in breast cancer tissue. [Seoul]: Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.
Buscar texto completoBonavida, Benjamin. Chemo-immunosensitization of resistant tumor cells to cell death by apoptosis, 2006. Trivandrum: Transworld Research Network, 2006.
Buscar texto completoJulia, Gee, Nicholson Robert I y SpringerLink (Online service), eds. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New Molecular Aspects and their Potential as Targets. Dordrecht: Springer Netherlands, 2009.
Buscar texto completo1940-, Tabuchi K., ed. Biological aspects of brain tumors: Proceedings of the 8th Nikko Brain Tumor Conference, Karatsu (Saga) 1990. Tokyo: Springer-Verlag, 1991.
Buscar texto completoGregory, Bock, Goode Jamie, Novartis Foundation y Symposium on Mechanisms of Drug Resistance in Epilepsy : Lessons from Oncology (2001 : London, England), eds. Mechanisms of drug resistance in epilepsy: Lessons from oncology. Chichester, England: Wiley, 2002.
Buscar texto completoCapítulos de libros sobre el tema "Cancer drug resistance, tumor metabolism"
Park, Joshua K., Nathan J. Coffey, Aaron Limoges y Anne Le. "The Heterogeneity of Lipid Metabolism in Cancer". En The Heterogeneity of Cancer Metabolism, 39–56. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-65768-0_3.
Texto completoWahl, Daniel, Michael Petronek, Rashmi Ramachandran, John Floberg, Bryan G. Allen y Julie K. Schwarz. "Targeting Tumor Metabolism to Overcome Radioresistance". En Cancer Drug Discovery and Development, 219–63. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-49701-9_10.
Texto completoMashima, Tetsuo, Hiroyuki Seimiya, Zhihong Chen, Shiro Kataoka y Takashi Tsuruo. "Apoptosis resistance in tumor cells". En Multiple Drug Resistance in Cancer 2, 293–308. Dordrecht: Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-017-2374-9_20.
Texto completoBoros, László G., Richard D. Beger, Emmanuelle J. Meuillet, Jerry R. Colca, Sándor Szalma, Patricia A. Thompson, László Dux, Gyula Farkas y Gábor Somlyai. "Targeted 13C-Labeled Tracer Fate Associations for Drug Efficacy Testing in Cancer". En Tumor Cell Metabolism, 349–72. Vienna: Springer Vienna, 2015. http://dx.doi.org/10.1007/978-3-7091-1824-5_15.
Texto completoSaeed, Mohamed, Henry Johannes Greten y Thomas Efferth. "Collateral Sensitivity in Drug-Resistant Tumor Cells". En Resistance to Targeted Anti-Cancer Therapeutics, 187–211. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7070-0_10.
Texto completoLundholm, Kent G. "Tumor Host Metabolism and Nutrient Delivery in Cancer Treatment". En Drug Delivery in Cancer Treatment, 29–37. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-73077-1_4.
Texto completoSiddik, Zahid H. "Drug Resistance and the Tumor Suppressor p53: The Paradox of Wild-Type Genotype in Chemorefractory Cancers". En Drug Resistance in Cancer Cells, 209–31. New York, NY: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-89445-4_9.
Texto completoMitchell, James B., Angelo Russo, John A. Cook y Eli Glatstein. "Tumor cell drug and radiation resistance: Does an interrelationship exist?" En Cancer Treatment and Research, 189–203. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1601-5_12.
Texto completoDavis, Alison J. y Ian F. Tannock. "Tumor Physiology and Resistance to Chemotherapy: Repopulation and Drug Penetration". En Cancer Treatment and Research, 1–26. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-1173-1_1.
Texto completoBroxterman, Henk J. y Carolien H. M. Versantvoort. "Pharmacology of Drug Transport in Multidrug Resistant Tumor Cells". En Alternative Mechanisms of Multidrug Resistance in Cancer, 67–80. Boston, MA: Birkhäuser Boston, 1995. http://dx.doi.org/10.1007/978-1-4615-9852-7_3.
Texto completoActas de conferencias sobre el tema "Cancer drug resistance, tumor metabolism"
Taylor, Holly, Jaroslav Slamecka, Alla Musiyenko, Elaine Gavin, Tiffany S. Norton, Ileana Aragon, Taylor Young et al. "Abstract B31: Tumor-intrinsic B7-H3 regulates drug resistance, metabolism, and pathogenesis in ovarian cancer". En Abstracts: AACR Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; October 1-4, 2017; Pittsburgh, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1557-3265.ovca17-b31.
Texto completoLiu, Jiawei. "Metabolism, Metastasis and Drug Resistance in Cancer". En The International Conference on Biomedical Engineering and Bioinformatics. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011311900003443.
Texto completoOkon, Imoh S., Kathleen A. Coughlan y Ming-Hui Zou. "Abstract B24: Attenuated expression of a novel mitochondrial and metabolic gene contributes to acquired gefitinib resistance in lung tumors". En Abstracts: AACR Precision Medicine Series: Drug Sensitivity and Resistance: Improving Cancer Therapy; June 18-21, 2014; Orlando, FL. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1557-3265.pms14-b24.
Texto completoAchuthan, Santhi, Richard Callaghan y Anneke C. Blackburn. "Abstract A90: Dichloroacetate can overcome drug resistance via decreased ABC drug transporter expression and PDK2 inhibition". En Abstracts: AACR Special Conference: Metabolism and Cancer; June 7-10, 2015; Bellevue, WA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3125.metca15-a90.
Texto completoYu, Tengfei, Ying Yan, Wei Du, Yuefei Yang, Tingting Tan, Xuqin Yang, Jiali Gu, Liang Hua, Xin K. Ye y Zhenyu Gu. "Abstract 1212: Studying cancer drug resistance in patient derived xenograft tumor models". En Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1212.
Texto completoNwosu, ZC, W. Pioronska, MP Ebert, C. Meyer y S. Dooley. "Glutamine deprivation link impaired metabolism to ERK pathway activation and drug resistance in liver cancer". En 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0038-1677176.
Texto completoJayaprakash, Priyamvada, Michael Curran, Brittany Morrow, Joseph Marszalek, Krithikaa Rajkumar Bhanu, Meghan Rice, Jason Gay, Christopher Vellano, Benjamin Cowen y Dean Welsch. "831 Targeting tumor oxidative metabolism to overcome hypoxia-induced immunotherapy resistance in prostate cancer". En SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0831.
Texto completoSettleman, Jeffrey. "Modeling drug sensitivity and resistance in human tumor-derived cell lines". En AACR International Conference: Molecular Diagnostics in Cancer Therapeutic Development– Sep 27-30, 2010; Denver, CO. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/diag-10-pl1-1.
Texto completoRaja, Vaishnavi, Shailendra Giri, Suhail Hamid, Adnan R. Munkarah y Ramandeep Rattan. "Abstract GMM-049: STAT3 PROMOTES OVARIAN CANCER GROWTH AND DRUG RESISTANCE BY MODULATING THE ENERGY METABOLISM". En Abstracts: 12th Biennial Ovarian Cancer Research Symposium; September 13-15, 2018; Seattle, Washington. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1557-3265.ovcasymp18-gmm-049.
Texto completoStuart, Shawn D., Moises Guardado, Michael Dahan, Paul M. Bingham y Zuzana Zachar. "Abstract A61: Tumor metabolic remodeling can modulate anticancer drug response: CPI-613 attack on tumor cell mitochondrial metabolism is mediated by metabolite availability". En Abstracts: AACR Special Conference: Metabolism and Cancer; June 7-10, 2015; Bellevue, WA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3125.metca15-a61.
Texto completoInformes sobre el tema "Cancer drug resistance, tumor metabolism"
Liu, Shuang, Zheng-Miao Wang, Dong-Mei Lv y Yi-Xuan Zhao. Advances in highly active one-carbon metabolism in cancer diagnosis, treatment, and drug resistance: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, noviembre de 2022. http://dx.doi.org/10.37766/inplasy2022.11.0099.
Texto completoSpanjaard, Remco A. Role of ei24/PIG8, A Putative Pro-Apoptotic Tumor Suppressor, in Breast Cancer Development and Resistance to Drug Therapy. Fort Belvoir, VA: Defense Technical Information Center, marzo de 2005. http://dx.doi.org/10.21236/ada433856.
Texto completo